These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3860286)

  • 1. Isolation and characterization of an anthracycline-resistant human leukemic cell line.
    Bhalla K; Hindenburg A; Taub RN; Grant S
    Cancer Res; 1985 Aug; 45(8):3657-62. PubMed ID: 3860286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance.
    Hindenburg AA; Baker MA; Gleyzer E; Stewart VJ; Case N; Taub RN
    Cancer Res; 1987 Mar; 47(5):1421-5. PubMed ID: 3469017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K; Nayak R; Grant S
    Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of multifactorial mechanisms in an adriamycin-resistant HL-60 promyelocytic leukemia cell line.
    Burres NS; Myers MT; Sartorelli AC
    Cancer Biochem Biophys; 1988 Jul; 10(1):47-57. PubMed ID: 3224331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells.
    Hindenburg AA; Gervasoni JE; Krishna S; Stewart VJ; Rosado M; Lutzky J; Bhalla K; Baker MA; Taub RN
    Cancer Res; 1989 Aug; 49(16):4607-14. PubMed ID: 2545346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines.
    Cass CE; Janowska-Wieczorek A; Lynch MA; Sheinin H; Hindenburg AA; Beck WT
    Cancer Res; 1989 Nov; 49(21):5798-804. PubMed ID: 2790792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate.
    Arkin H; Ohnuma T; Kamen BA; Holland JF; Vallabhajosula S
    Cancer Res; 1989 Dec; 49(23):6556-61. PubMed ID: 2573416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of adriamycin-resistant HL-60 cells which are not defective in the initial intracellular accumulation of drug.
    Marsh W; Sicheri D; Center MS
    Cancer Res; 1986 Aug; 46(8):4053-7. PubMed ID: 2425939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.
    Watanabe M; Komeshima N; Naito M; Isoe T; Otake N; Tsuruo T
    Cancer Res; 1991 Jan; 51(1):157-61. PubMed ID: 1988080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells.
    Lutzky J; Astor MB; Taub RN; Baker MA; Bhalla K; Gervasoni JE; Rosado M; Stewart V; Krishna S; Hindenburg AA
    Cancer Res; 1989 Aug; 49(15):4120-5. PubMed ID: 2568167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a human myeloid leukemia cell line highly resistant to taxol.
    Bhalla K; Huang Y; Tang C; Self S; Ray S; Mahoney ME; Ponnathpur V; Tourkina E; Ibrado AM; Bullock G
    Leukemia; 1994 Mar; 8(3):465-75. PubMed ID: 7907395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of uridine on response of 5-azacytidine-resistant human leukemic cells to inhibitors of de novo pyrimidine synthesis.
    Grant S; Bhalla K; Gleyzer M
    Cancer Res; 1984 Dec; 44(12 Pt 1):5505-10. PubMed ID: 6208998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of the intracellular accumulation and DNA binding of idarubicin and daunorubicin in sensitive and multidrug-resistant human leukaemia K562 cells.
    Bogush T; Robert J
    Anticancer Res; 1996; 16(1):365-8. PubMed ID: 8615637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug sensitivity and cross-resistance of the 4'-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia.
    Odaimi M; Andersson BS; McCredie KB; Beran M
    Cancer Res; 1986 Jul; 46(7):3330-3. PubMed ID: 3754787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells.
    Côme MG; Skladanowski A; Larsen AK; Laurent G
    Br J Cancer; 1999 Mar; 79(7-8):1090-7. PubMed ID: 10098741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of verapamil on daunomycin cellular retention and cytotoxicity in P388 leukemic cells.
    Yanovich S; Preston L
    Cancer Res; 1984 May; 44(5):1743-7. PubMed ID: 6713377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells.
    Frank DA; Sartorelli AC
    Cancer Res; 1988 Jan; 48(1):52-8. PubMed ID: 2825968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in daunomycin retention in sensitive and resistant P388 leukemic cells as determined by digitized video fluorescence microscopy.
    Yanovich S; Taub RN
    Cancer Res; 1983 Sep; 43(9):4167-71. PubMed ID: 6871858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.
    Klohs WD; Steinkampf RW; Havlick MJ; Jackson RC
    Cancer Res; 1986 Sep; 46(9):4352-6. PubMed ID: 3460695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.